Surgical oncologist who co-directs NCT/UCC Dresden and leads gastrointestinal cancer surgery at University Hospital Carl Gustav Carus.
Jürgen Weitz is a Managing Director of the National Center for Tumor Diseases (NCT/UCC) Dresden and Director of the Department of Visceral, Thoracic and Vascular Surgery at University Hospital Carl Gustav Carus, TU Dresden. His clinical and research work centres on surgical oncology of colorectal, pancreatic and hepatobiliary cancers, including surgical trials and technology-assisted surgery. His role is listed on the NCT/UCC Direktorium page.
| Title | Journal | Year |
|---|---|---|
| Mouse Models of Human Gastric Cancer Subtypes With Stomach-Specific CreERT2-Mediated Pathway Alterations | Gastroenterology | 2019 |
| Oncological liver resection in elderly – A retrospective comparative study | International Journal of Surgery | 2022 |
| Transfusions of packed red blood cells in surgery for liver cancer: predictor of impaired overall survival but not recurrence-free survival – impact of blood transfusions in liver surgery | Journal of Gastrointestinal Surgery | 2024 |
Shares Borderline resectable pancreatic ductal adenocarcinoma, Resectable pancreatic ductal adenocarcinoma, Pancreatic ductal adenocarcinoma and the tags leadership, clinician-scientist, surgical oncology.
Shares NCT/UCC Dresden, University Hospital Carl Gustav Carus and the tags leadership, clinician-scientist.
Shares Colorectal cancer and the tags leadership, clinician-scientist, gastrointestinal cancer.
Shares NCT/UCC Dresden, University Hospital Carl Gustav Carus and the tags leadership, clinician-scientist.
Shares Colorectal cancer and the tags leadership, clinician-scientist, surgical oncology.
Shares Borderline resectable pancreatic ductal adenocarcinoma, Resectable pancreatic ductal adenocarcinoma.
Shares Borderline resectable pancreatic ductal adenocarcinoma, Resectable pancreatic ductal adenocarcinoma.
Shares Borderline resectable pancreatic ductal adenocarcinoma, Resectable pancreatic ductal adenocarcinoma.